Iñigo Lorenzo Ruiz1,2, Larraitz Gaztañaga Arantzamendi3, Xabier Marichalar Mendia4. 1. Nursing Department I, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Sarriena, Leioa, Spain. inigo.lorenzo@ehu.eus. 2. BioCruces-Bizkaia Health Research Institute, Baracaldo, Spain. inigo.lorenzo@ehu.eus. 3. Basurto University Hospital, Montevideo 18, 48013, Bilbao, Bizkaia, Spain. 4. Nursing Department I, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Sarriena, Leioa, Spain.
Abstract
BACKGROUND: Postmortem explanted cardiac implantable electronic devices (CIEDs) from developed countries could provide patients unable to afford new devices in low- and middle-income countries (LMIC) a treatment they lack. This study describes the preferences of electrophysiologists and device implanting cardiologists from Spain on the management of explanted CIEDs and opinions and concerns regarding reuse in LMIC. METHODS: A nationwide self-administered questionnaire was sent to members of the Spanish Rhythm Association (n = 1110), between December 2020 and January 2021. RESULTS: Forty-two physician responses were obtained (response rate 5%). There was a strong preference to donate explanted devices for reuse in humans (61.9%) or animals (31%). The vast majority of the participants thought device reutilization was safe, ethical, and a reasonable alternative if a new device is not accessible. Moreover, they indicated they would be comfortable asking patients to consider post-mortem donation, and willing to implant post-mortem explanted and resterilized devices if they were unable to obtain new ones. 57.1% of respondents considered it would be beneficial for patients to have a document so they could reflect their wishes regarding device handling after their death. The most mentioned concerns regarding device reuse were malfunction (57.1%) and infection (54.8%). CONCLUSIONS: The majority of respondents support reusable CIED donation to LMIC. It would be interesting to study the feasibility of a nationwide device reutilization program.
BACKGROUND: Postmortem explanted cardiac implantable electronic devices (CIEDs) from developed countries could provide patients unable to afford new devices in low- and middle-income countries (LMIC) a treatment they lack. This study describes the preferences of electrophysiologists and device implanting cardiologists from Spain on the management of explanted CIEDs and opinions and concerns regarding reuse in LMIC. METHODS: A nationwide self-administered questionnaire was sent to members of the Spanish Rhythm Association (n = 1110), between December 2020 and January 2021. RESULTS: Forty-two physician responses were obtained (response rate 5%). There was a strong preference to donate explanted devices for reuse in humans (61.9%) or animals (31%). The vast majority of the participants thought device reutilization was safe, ethical, and a reasonable alternative if a new device is not accessible. Moreover, they indicated they would be comfortable asking patients to consider post-mortem donation, and willing to implant post-mortem explanted and resterilized devices if they were unable to obtain new ones. 57.1% of respondents considered it would be beneficial for patients to have a document so they could reflect their wishes regarding device handling after their death. The most mentioned concerns regarding device reuse were malfunction (57.1%) and infection (54.8%). CONCLUSIONS: The majority of respondents support reusable CIED donation to LMIC. It would be interesting to study the feasibility of a nationwide device reutilization program.
Authors: Sachin Logani; Maia Gottlieb; Ralph J Verdino; Timir S Baman; Kim A Eagle; James N Kirkpatrick Journal: Pacing Clin Electrophysiol Date: 2011-02-11 Impact factor: 1.976
Authors: Kevin Wunderly; Zaheer Yousef; Aimé Bonny; Kevin J Weatherwax; Balasundaram Lavan; Craig Allmendinger; Brad Wasserman; George Samson; Sheldon Davis; George Nel; James Russell; Constantine Akwanalo; Mahmoud U Sani; Ashely Chin; Olujimi A Ajijola; Bongani M Mayosi; Kim A Eagle; Thomas C Crawford Journal: Nat Rev Cardiol Date: 2018-12 Impact factor: 32.419
Authors: Andrew B Hughey; Nimit Desai; Timir S Baman; Lindsey Gakenheimer; Lindsay Hagan; James N Kirkpatrick; Hakan Oral; Kim A Eagle; Thomas C Crawford Journal: Pacing Clin Electrophysiol Date: 2014-05-01 Impact factor: 1.976
Authors: Mason W Runge; Timir S Baman; Sheldon Davis; Kevin Weatherwax; Ed Goldman; Kim A Eagle; Thomas C Crawford Journal: World J Cardiol Date: 2017-04-26